Overall survival Up to 5 years [clinicaltrials_resource:f85a0d14999f57ec8221b9ca1ee6782b]
Patients receive a single dose of IV paclitaxel over 3 hours. Additional cycles of paclitaxel will be given at the discretion of the physician.
Patients are followed for second malignancies, disease progression, and survival.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Overall survival Up to 5 years [clinicaltrials_resource:f85a0d14999f57ec8221b9ca1ee6782b]
Patients receive a single dose of IV paclitaxel over 3 hours. Additional cycles of paclitaxel will be given at the discretion of the physician.
Patients are followed for second malignancies, disease progression, and survival.
Bio2RDF identifier
f85a0d14999f57ec8221b9ca1ee6782b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f85a0d14999f57ec8221b9ca1ee6782b
measure [clinicaltrials_vocabulary:measure]
Overall survival
time frame [clinicaltrials_vocabulary:time-frame]
Up to 5 years
description
Patients receive a single dose ...... ase progression, and survival.
identifier
clinicaltrials_resource:f85a0d14999f57ec8221b9ca1ee6782b
title
Overall survival Up to 5 years
@en
type
label
Overall survival Up to 5 years [clinicaltrials_resource:f85a0d14999f57ec8221b9ca1ee6782b]
@en